The PIK3CA detection rates in basal-like (38.24%, 13/34) were higher than in luminal B (31.67, 19/60), HER2+ (30.61%, 15/49), and luminal A (26.98 %, 17/63) breast cancers (Figure 3A). This evidence concerns the gene PIK3CA and breast cancer.